During the past decade, University of Leipzig - Heart Center conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 1 clinical trials were completed, i.e. on average, 8.3% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Leipzig - Heart Center" #1 sponsor was "University of Leipzig" with 21 trials, followed by "Heart Center Leipzig - University Hospital" with 9 trials sponsored, "HLT Inc." with 1 trials sponsored, "Holger Thiele" with 1 trials sponsored and "Medtronic Cardiac Rhythm and Heart Failure" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Leipzig - Heart Center" #1 collaborator was "Heart Center Leipzig - University Hospital" with 2 trials as a collaborator, "Cordis Medizinische Apparate GmbH" with 1 trials as a collaborator, "Deutsche Stiftung für Herzforschung" with 1 trials as a collaborator, "Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK)" with 1 trials as a collaborator and "European Commission" with 1 trials as a collaborator. Other collaborators include 4 different institutions and companies that were collaborators in the rest 14 trials.

According to Clinical.Site data, the most researched conditions in "University of Leipzig - Heart Center" are "Myocardial Infarction" (7 trials), "Coronary Artery Disease" (3 trials), "Heart Failure With Preserved Ejection Fraction" (2 trials), "Impaired Glucose Tolerance" (2 trials) and "Obesity" (2 trials). Many other conditions were trialed in "University of Leipzig - Heart Center" in a lesser frequency.

Most popular intervention types in "University of Leipzig - Heart Center" are "Device" (14 trials), "Other" (8 trials), "Drug" (6 trials), "Procedure" (6 trials) and "Diagnostic Test" (4 trials). Other intervention types were less common.

The name of intervention was led by "exercise training" (2 trials), "Abciximab i.c." (1 trials), "Abciximab i.v." (1 trials), "Acetylcystein" (1 trials) and "Acquisition of pressure-volume-loops" (1 trials). Other intervention names were less common.

The vast majority of trials in "University of Leipzig - Heart Center" are 33 trials for "All" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "University of Leipzig - Heart Center". undefined are not yet recruiting, 4 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 23 completed trials in University of Leipzig - Heart Center, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in University of Leipzig - Heart Center, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 10 trials, and there were also 11 trials that are defined as “Not Applicable".